Advertisement
Research Article

Characteristics and Impact of Drug Detailing for Gabapentin

  • Michael A Steinman mail,

    To whom correspondence should be addressed. E-mail: mike.steinman@ucsf.edu

    Affiliations: San Francisco Veterans Affairs Medical Center, San Francisco, California, United States of America, Division of Geriatrics, University of California, San Francisco, California, United States of America

    X
  • G. Michael Harper,

    Affiliations: San Francisco Veterans Affairs Medical Center, San Francisco, California, United States of America, Division of Geriatrics, University of California, San Francisco, California, United States of America

    X
  • Mary-Margaret Chren,

    Affiliations: San Francisco Veterans Affairs Medical Center, San Francisco, California, United States of America, Department of Dermatology, University of California, San Francisco, California, United States of America

    X
  • C. Seth Landefeld,

    Affiliations: San Francisco Veterans Affairs Medical Center, San Francisco, California, United States of America, Division of Geriatrics, University of California, San Francisco, California, United States of America

    X
  • Lisa A Bero

    Affiliations: Department of Clinical Pharmacy, University of California, San Francisco, California, United States of America, Institute for Health Policy Studies, University of California, San Francisco, California, United States of America

    X
  • Published: April 24, 2007
  • DOI: 10.1371/journal.pmed.0040134

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.